<DOC>
	<DOCNO>NCT01588327</DOCNO>
	<brief_summary>The ability explain bleed clot complication patient treat dabigatran remain challenge . In addition , limited data coagulation test perform patient treat therapeutic dos dabigatran . Predicted response coagulation test therapeutic dos dabigatran may helpful good understand abnormal response dabigatran . The purpose study define therapeutic reference range peak trough coagulation test patient take FDA approve dos dabigatran determine test may clinically useful monitoring dabigatran .</brief_summary>
	<brief_title>A Prospective Pharmacodynamic Study Dabigatran</brief_title>
	<detailed_description />
	<mesh_term>Dabigatran</mesh_term>
	<criteria>â€¢ Medication therapy dabigatran 75 mg twice daily 150 mg twice daily minimum 3 day CrCl &lt; 15 ml/min NonFDA approve dose base calculate CrCl recent SCr Age &lt; 18 year Inability communicate English language Decisionallyimpaired individual Incarcerated Pregnant/Lactating ( Pregnancy category : C , unevaluated effect lactation )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>